Orthostatic Hypotension in Hypertensive Patient Hospitalized in Internal Medicine
NCT05247060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-02-28
Summary
The two scientific societies FADOI and SIIA have decided to start a collaborative study protocol that, through the application of a simple and homogeneous method to diagnose orthostatic hypotension, aims to estimate prevalence, conditions associates and outcomes in a cohort of patients admitted to Internal Medicine Departments and with known or newly diagnosed arterial hypertension.
Conditions
- Hospitalization
Interventions
- OTHER
-
no experimental intervention
There will not be any experimental intervention. The study will be conducted according with normal clinical practice
Sponsors & Collaborators
-
Fadoi Foundation, Italy
lead OTHER
Principal Investigators
-
Andrea Fontanella, MD · FADOI FOUNDATION
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-16
- Primary Completion
- 2023-06-30
- Completion
- 2024-02-20
Countries
- Italy
Study Locations
More Related Trials
-
Study on Blood Pressure Variability and Frailty in the Older People
NCT06868069 ·Status: RECRUITING
-
Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives
NCT00508365 ·Status: COMPLETED ·Phase: PHASE1
-
Essential Hypotension and Allostasis Registry
NCT02018497 ·Status: UNKNOWN
-
Phenotypisation of Sleep Pattern in Hypertensive Patients With Non Dipper Pattern
NCT06302738 ·Status: RECRUITING
-
Hyponatremia in the Prevention of Hospitalized Patients Falls
NCT03265691 ·Status: COMPLETED ·Phase: NA
-
Peripheral Dopamine in Postural Tachycardia Syndrome
NCT00685919 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effects of Blood Pressure Reduction on Cerebral Perfusion and Cognition in the Elderly Population
NCT00966199 ·Status: UNKNOWN ·Phase: PHASE4
-
Changes in Renal Function and Body Composition in Pulmonary Hypertension
NCT03039972 ·Status: COMPLETED
-
Phenotyping of the Out-of-proportion Pulmonary Hypertension
NCT06051396 ·Status: RECRUITING
-
Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening
NCT01783288 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Renin-Angiotensin System Inhibitors and COVID-19
NCT04331574 ·Status: UNKNOWN
-
The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
NCT00962949 ·Status: COMPLETED ·Phase: PHASE1
-
Monitoring of the Influence of Approved PH-therapies RV-PA Coupling
NCT05935865 ·Status: RECRUITING
-
Impact of Reducing Antihypertensive Treatment on Mortality in Frail Subjects With Low Systolic Blood Pressure (SBP).
NCT03453268 ·Status: COMPLETED ·Phase: NA
-
Adherence of Diuretics in Pulmonary Hypertension
NCT05167968 ·Status: COMPLETED
-
Dietary Sodium's Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome
NCT01563107 ·Status: COMPLETED ·Phase: NA
-
National Survey on Hypertension at Hospital
NCT00695266 ·Status: COMPLETED
-
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
NCT01292694 ·Status: TERMINATED ·Phase: PHASE1
-
Accomplices of Insulin Resistance in Prehypertension: Aldosterone?
NCT01112007 ·Status: COMPLETED
-
Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients
NCT00135551 ·Status: COMPLETED ·Phase: PHASE4
-
Nocturnal Blood Pressure Dipping and Ventricular Repolarization in Hypertension
NCT07200856 ·Status: NOT_YET_RECRUITING
-
Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension
NCT02603809 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Antihypertensive Drug Treatment on Brain Blood Flow, Cognition, and Regulation of Nervous System in Older Adults With Hypertension.
NCT06287580 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study
NCT00408512 ·Status: COMPLETED ·Phase: PHASE4
-
Hypertension Prevention in Pre-Hypertensive Individuals
NCT00970931 ·Status: COMPLETED ·Phase: PHASE3